MBX BIOSCIENCES INC. news, videos and press releases
For more news please use our advanced search feature.
MBX BIOSCIENCES INC. - More news...
MBX BIOSCIENCES INC. - More news...
- MBX Biosciences to Participate in Upcoming February Investor Conferences
- MBX Biosciences Announces Positive Phase 1 Topline Results for MBX 1416 for the Treatment of Post-bariatric Hypoglycemia
- MBX Biosciences to Participate in 43rd Annual J.P. Morgan Healthcare Conference
- MBX Biosciences Announces MBX 2109 Phase 1 Study Results Published in The Journal of Clinical Endocrinology and Metabolism
- MBX Biosciences Announces Last Subject Last Visit in Phase 1 Trial of MBX 1416 for the Treatment of Post-Bariatric Hypoglycemia
- MBX Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update
- MBX Biosciences to Participate in Upcoming November Investor Conferences
- MBX Biosciences Presents MBX 2109 Phase 2 Avail™ Hypoparathyroidism Trial Rationale and Design at the ASBMR 2024 Annual Meeting
- MBX Biosciences Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
